Increased Risk of Breakthrough Infection among Cytomegalovirus Donor Positive/Recipient Negative Kidney Transplant Recipients Receiving Lower Dose Valganciclovir Prophylaxis

被引：0
|
作者：
Stevens, D. [1 ]
Trofe-Clark, J. [1 ,2 ]
Blumberg, E. [2 ]
Wilck, M. [2 ]
Weikert, B. [2 ]
Goral, S. [2 ]
Bleicher, M. [2 ]
Sawinski, D. [2 ]
Abt, P. [2 ]
Levine, M. [2 ]
Porrett, P. [2 ]
Bloom, R. [2 ]
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [1] Increased risk of breakthrough infection among cytomegalovirus donor positive/recipient negative kidney transplant recipients receiving lower dose valganciclovir prophylaxis
    Stevens, Daniel R.
    Trofe-Clark, Jennifer
    Blumberg, Emily
    Wilck, Marissa
    Weikert, Blair
    Goral, Simin
    Bleicher, Melissa
    Sawinski, Deirdre
    Abt, Peter L.
    Levine, Matthew H.
    Porrett, Paige
    Galanakis, Nicholas
    Bloom, Roy D.
    PHARMACOTHERAPY, 2013, 33 (10): : E238 - E239
  • [2] Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis
    Stevens, D. R.
    Sawinski, D.
    Blumberg, E.
    Galanakis, N.
    Bloom, R. D.
    Trofe-Clark, J.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (02) : 163 - 173
  • [3] Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis
    Mitsani, Dimitra
    Nguyen, M. Hong
    Kwak, Eun J.
    Silveira, Fernanda P.
    Vadnerkar, Aniket
    Pilewski, Joseph
    Crespo, Maria
    Toyoda, Yoshiya
    Bermudez, Christian
    Clancy, Cornelius J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (09): : 1014 - 1020
  • [4] Standard Dose Valganciclovir Prophylaxis for High-Risk Kidney Transplant Recipients Reduces Incidences of Breakthrough and Resistant Cytomegalovirus Infection.
    Huang, Y.
    Park, J.
    Naik, A.
    Kaul, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 777 - 777
  • [5] Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis
    Liang, Xinyun
    Famure, Olusegun
    Li, Yanhong
    Kim, S. Joseph
    PROGRESS IN TRANSPLANTATION, 2018, 28 (02) : 124 - 133
  • [6] Expanded valganciclovir prophylaxis in kidney transplant recipients is associated with lower incidence of cytomegalovirus infection
    Veceric-Haler, Zeljka
    Bizjak, Bostjan
    Romozi, Karmen
    Arnol, Miha
    CLINICAL NEPHROLOGY, 2017, 88 : S126 - S130
  • [7] EXTENDING VALGANCICLOVIR PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS IS ASSOCIATED WITH LOWER INCIDENCE OF CYTOMEGALOVIRUS INFECTION
    Bizjak, Bostjan
    Veceric-Haler, Zeljka
    Romozi, Karmen
    Arnol, Miha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 407 - 407
  • [8] Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients
    Luan, F. L.
    Samaniego, M.
    Kommareddi, M.
    Park, J. M.
    Ojo, A. O.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (06) : 473 - 479
  • [9] Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir
    Nanmoku, K.
    Shinzato, T.
    Kubo, T.
    Shimizu, T.
    Kimura, T.
    Yagisawa, T.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 124 - 129
  • [10] Increased Incidence of Cytomegalovirus Infection in High-Risk Liver Transplant Recipients Receiving Valganciclovir Prophylaxis Versus Ganciclovir Prophylaxis
    Shiley, Kevin T.
    Gasink, Leanne B.
    Barton, Todd D.
    Pfeiffenberger, Patrice
    Olthoff, Kim M.
    Blumberg, Emily A.
    LIVER TRANSPLANTATION, 2009, 15 (08) : 963 - 967
12345